Abiopharma

Financial Statements and Related Announcement: Half Yearly Results

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/ Changes in Interest of a Director - Goi Seng Hui

Full Year Results 2026

BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base

BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

SFL - Invitation to Presentation of Q2 2026 Results

Paysafe Becomes Envision Racing Title Partner to Build the Future of Fan Engagement; Where Motorsport, Gaming and Payments Become One

General Announcement: NET ASSET VALUE PER SHARE

A Letter from CEO regarding the Special Meeting of Stockholders

Pursuant to Rule 425 under the Securities Act of 1933